Publications by authors named "Xinghui Huang"
Purpose: To develop and validate a predictive model for the risk of death in patients with () bloodstream infection (BSI) for clinical decision-making and patient management.
Methods: In this study, we included demographic and clinical data from 206 patients with BSI in China between January 2013 and December 2023. Variables were screened by least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression, and prognostic models and nomograms were constructed.
Article Synopsis
- - Transarterial chemoembolization (TACE) is a common treatment for advanced hepatocellular carcinoma (HCC), but there is a need for better methods to measure its effectiveness in real-time.
- - Researchers analyzed circulating free DNA (cfDNA) from HCC patients to see if it could help predict treatment responses and outcomes; they found that changes in tumor fraction (TFx) during treatment were closely tied to tumor burden and prognosis.
- - Findings suggest that copy number variations (CNVs) in cfDNA could be used as biomarkers, with specific amplifications indicating worse responses and influencing lipiodol deposition, offering a potential new method for managing TACE in HCC patients.